Timothy J. Barberich - 15 Jul 2021 Form 3 Insider Report for TScan Therapeutics, Inc. (TCRX)

Role
Director
Signature
/s/ Timothy J Barberich
Issuer symbol
TCRX
Transactions as of
15 Jul 2021
Net transactions value
$0
Form type
3
Filing time
15 Jul 2021, 18:21:02 UTC
Previous filing
30 Jun 2021
Next filing
22 Jul 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TCRX Stock Option (right to buy) 15 Jul 2021 Voting Common Stock 27,808 $1.97 Direct F1
holding TCRX Stock Option (right to buy) 15 Jul 2021 Voting Common Stock 20,082 $2.46 Direct F2
holding TCRX Series B Preferred Stock 15 Jul 2021 Voting Common Stock 33,259 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option vest in 48 equal monthly installments following January 24, 2019.
F2 The shares subject to this option vest over 4 years of service following December 5, 2019, with 25% vesting upon completion of 1 year of continuous service to the Issuer and the balance vesting in 36 equal monthly installments thereafter.
F3 Each share of the Issuer's Series B Preferred Stock is convertible into shares of the Issuer's Voting Common Stock on a 1 for 1 basis at the holder's election and will automatically convert immediately prior to the closing of the Issuer's initial public offering. These shares have no expiration date.